Advertisement

Topics

$TEVA FDA Approval of AJOVYTM (fremanezumab-vfrm) Injection for the Preventive Treatment of Migraine in Adults http://www.tevapharm.com/news/teva_announces_u_s_approval_of_ajovytm_fremanezumab_vfrm_injection_the_first_and_only_anti_cgrp_treatment_with_bo

01:01 EDT 15 Sep 2018 | Odi Bruckman

FDA Approval of AJOVYTM (fremanezumab-vfrm) Injection for the Preventive Treatment of Migraine in Adults http://www.tevapharm.com/news/teva_announces_u_s_approval_of_ajovytm_fremanezumab_vfrm_injection_the_first_and_only_anti_cgrp_treatment_with_both_quarterly_and_monthly_dosing_for_the_preventive_treatment_of_migraine_in_adults_09_18.aspx …

Original Article: $TEVA FDA Approval of AJOVYTM (fremanezumab-vfrm) Injection for the Preventive Treatment of Migraine in Adults http://www.tevapharm.com/news/teva_announces_u_s_approval_of_ajovytm_fremanezumab_vfrm_injection_the_first_and_only_anti_cgrp_treatment_with_bo

NEXT ARTICLE

More From BioPortfolio on "$TEVA FDA Approval of AJOVYTM (fremanezumab-vfrm) Injection for the Preventive Treatment of Migraine in Adults http://www.tevapharm.com/news/teva_announces_u_s_approval_of_ajovytm_fremanezumab_vfrm_injection_the_first_and_only_anti_cgrp_treatment_with_bo"

Advertisement
Quick Search
Advertisement
Advertisement